Dr. Karin Rodland’s many achievements include her decades long commitment to the application of cutting-edge mass spectrometry technologies to compelling biological problems. She has provided biological focus to the proteomics group at PNNL since 2002, insuring that the technologies were applied to the most significant biomedical problems and that issues of experimental design and data analysis reflected the needs of the biomedical community. Dr. Rodland has published extensively in the field of proteomics, on the use of mass spectrometry to further understanding of basic biological processes. She was among the first to characterize the role of the G-protein coupled calcium-sensing receptor in modulating proliferation-associated signal transduction pathways. However, her impact can be better quantified in terms of her unique ability to establish collaborations that bring cutting-edge proteomics technologies into the translational cancer medicine space through the application of proteogenomics to understand drug response and therapeutic resistance.
All Sessions by Karin Rodland
October 21, 2020
21:30
Closing Live Session
21:30 - 23:00 UTC
Closing Remarks Announcement of the PhD Poster and ECR Manuscript Winners HUPO Awards
Ben Collins, Ireland
Benjamin A. Garcia, United States
Fuchu He, China
Karin Rodland, United States
Melvin Park, United States
Oliver Raether, United States
Tadashi Yamamoto, Japan Announcement of HUPO 2021 Programme
Share
Karin Rodland
Let's Stay Connected!
Receive the latest information about the HUPO 2020 World Congress by submitting your information below.